An exploratory analysis of 5‐alpha reductase inhibitors and risk of opioid use disorder among male Medicare beneficiaries receiving prescription opioid medications

Documenti analoghi

• The Opioid Safety Toolkit: An interactive prescription opioid safety toolkit to increase opioid safety literacy and behaviours among people prescribed opioids for pain—a randomised controlled trial
  di: Suzanne Nielsen, et al.
  Pubblicazione: (2026)
• Evaluating the optimal duration of medication treatment for opioid use disorder
  di: Corey J. Hayes, et al.
  Pubblicazione: (2026)
• Medications for opioid use disorder: Predictors of early discontinuation and reduction of overdose risk in US military veterans by medication type
  di: Corey J. Hayes, et al.
  Pubblicazione: (2024)
• Impact of study design decisions on identification of treatment initiators of medications for opioid use disorder
  di: Payel J. Roy, et al.
  Pubblicazione: (2025)
• Refining cause of death attribution among opioid, opioid‐stimulant and stimulant acute toxicity deaths
  di: Yi‐Shin Grace Chang, et al.
  Pubblicazione: (2025)